Viatris Inc. is a global pharmaceutical company headquartered in Canonsburg, Pennsylvania, USA. Formed in November 2020 through the merger of Mylan and Pfizer's Upjohn division, it operates worldwide with approximately 30,000 employees and manufacturing sites across multiple countries.
The company develops, manufactures, and distributes a portfolio of over 1,400 approved molecules, including generic drugs, branded products (such as Lipitor, Viagra, and Xanax), biosimilars, over-the-counter medicines, and active pharmaceutical ingredients (APIs). Its therapeutic areas span cardiovascular, oncology, immunology, central nervous system and anesthesia, infectious diseases, women's healthcare, diabetes, gastroenterology, respiratory and allergy, dermatology, and more.
Viatris serves over 165 countries and territories, reaching about 1 billion patients annually. In the chemical industry context, it produces APIs and complex dosage forms like injectables and oral solids, supporting the pharmaceutical supply chain.
Official website: viatris.com
